miR-205: A Potential Biomedicine for Cancer Therapy.
Targeted Delivery
cancer
miR-205
miRNAs
nanoformulation
tumor suppressor
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
25 08 2020
25 08 2020
Historique:
received:
03
06
2020
revised:
18
08
2020
accepted:
21
08
2020
entrez:
29
8
2020
pubmed:
29
8
2020
medline:
16
4
2021
Statut:
epublish
Résumé
microRNAs (miRNAs) are a class of small non-coding RNAs that regulate the expression of their target mRNAs post transcriptionally. miRNAs are known to regulate not just a gene but the whole gene network (signaling pathways). Accumulating evidence(s) suggests that miRNAs can work either as oncogenes or tumor suppressors, but some miRNAs have a dual nature since they can act as both. miRNA 205 (miR-205) is one such highly conserved miRNA that can act as both, oncomiRNA and tumor suppressor. However, most reports confirm its emerging role as a tumor suppressor in many cancers. This review focuses on the downregulated expression of miR-205 and discusses its dysregulation in breast, prostate, skin, liver, gliomas, pancreatic, colorectal and renal cancers. This review also confers its role in tumor initiation, progression, cell proliferation, epithelial to mesenchymal transition, and tumor metastasis. Restoration of miR-205 makes cells more sensitive to drug treatments and mitigates drug resistance. Additionally, the importance of miR-205 in chemosensitization and its utilization as potential biomedicine and nanotherapy is described. Together, this review research article sheds a light on its application as a diagnostic and therapeutic marker, and as a biomedicine in cancer.
Identifiants
pubmed: 32854238
pii: cells9091957
doi: 10.3390/cells9091957
pmc: PMC7564275
pii:
doi:
Substances chimiques
MIRN205 microRNA, human
0
MicroRNAs
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : R01 CA210192
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA206069
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA204552
Pays : United States
Références
Gastroenterology. 2008 Oct;135(4):1322-32
pubmed: 18722373
Cell Death Differ. 2012 Sep;19(9):1525-35
pubmed: 22421968
Adv Exp Med Biol. 2015;815:197-216
pubmed: 25427909
Cancers (Basel). 2018 Aug 25;10(9):
pubmed: 30149628
Science. 2005 Jul 8;309(5732):310-1
pubmed: 15919954
BMC Med Genomics. 2012 Jan 19;5:3
pubmed: 22260379
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9
pubmed: 16166262
Biochem Biophys Res Commun. 2014 Feb 7;444(2):270-5
pubmed: 24462768
J Hepatol. 2012 Apr;56(4):952-64
pubmed: 22173168
Nucleic Acids Res. 2019 Jan 8;47(D1):D155-D162
pubmed: 30423142
Oncol Rep. 2013 Dec;30(6):2897-902
pubmed: 24084898
Cancer Res. 2005 Aug 15;65(16):7065-70
pubmed: 16103053
Mol Vis. 2006 Oct 17;12:1175-84
pubmed: 17102797
Cell. 2006 Mar 24;124(6):1169-81
pubmed: 16564011
Development. 2012 Apr;139(8):1405-16
pubmed: 22434867
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):299-306
pubmed: 29424887
Cell Death Dis. 2016 Jun 30;7(6):e2291
pubmed: 27362808
Oncol Lett. 2018 May;15(5):7571-7578
pubmed: 29725462
Bioinformatics. 2009 Apr 15;25(8):1091-3
pubmed: 19237447
J Exp Med. 2000 Mar 20;191(6):1005-16
pubmed: 10727462
Dev Biol. 2007 Feb 1;302(1):1-12
pubmed: 16989803
Anticancer Res. 2005 Jul-Aug;25(4):3123-33
pubmed: 16080576
Mol Cells. 2009 Dec 31;28(6):521-7
pubmed: 19937137
Am J Pathol. 2000 May;156(5):1515-25
pubmed: 10793063
J Clin Oncol. 2009 Apr 20;27(12):2030-7
pubmed: 19273703
Open Med (Wars). 2020 Mar 08;15:175-184
pubmed: 32190742
Crit Rev Oncog. 2013;18(1-2):43-73
pubmed: 23237552
Nucleic Acids Res. 2014 Jan;42(Database issue):D68-73
pubmed: 24275495
JAMA Oncol. 2015 Jul;1(4):505-27
pubmed: 26181261
Curr Pharm Biotechnol. 2014;15(9):829-38
pubmed: 25335533
Annu Rev Cell Dev Biol. 1997;13:513-609
pubmed: 9442882
Nature. 2000 Feb 24;403(6772):901-6
pubmed: 10706289
J Hum Genet. 2018 Feb;63(2):195-205
pubmed: 29196733
Cancer Res. 2009 Feb 1;69(3):879-86
pubmed: 19176371
Int J Clin Exp Med. 2015 Feb 15;8(2):3034-43
pubmed: 25932280
Methods Mol Biol. 2020;2148:257-276
pubmed: 32394388
Biochem Biophys Res Commun. 2005 Sep 9;334(4):1351-8
pubmed: 16039986
Biochem Biophys Res Commun. 2014 Mar 14;445(3):651-5
pubmed: 24576478
Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52
pubmed: 25378301
Eur J Cell Biol. 2013 Feb;92(2):54-60
pubmed: 23279926
Mod Pathol. 2016 Apr;29(4):330-46
pubmed: 26916073
Mol Med Rep. 2018 Sep;18(3):3242-3250
pubmed: 30066866
Br J Cancer. 2013 Apr 30;108(8):1668-76
pubmed: 23571738
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6116-24
pubmed: 17062688
J Biol Chem. 2011 May 13;286(19):16606-14
pubmed: 21454583
Int J Pharm Investig. 2015 Oct-Dec;5(4):179-81
pubmed: 26682187
Nucleic Acids Res. 2019 Apr 23;47(7):3353-3364
pubmed: 30820533
Saudi J Biol Sci. 2016 Sep;23(5):584-91
pubmed: 27579007
Cancer Res. 2007 Dec 15;67(24):11612-20
pubmed: 18089790
J Clin Oncol. 2013 Oct 10;31(29):3623-30
pubmed: 24002511
Small. 2011 Nov 18;7(22):3158-62
pubmed: 21922667
Curr Probl Cancer. 2010 Jan-Feb;34(1):14-37
pubmed: 20371072
Int J Oncol. 2013 Jul;43(1):307-14
pubmed: 23612742
Int J Urol. 2015 Sep;22(9):867-77
pubmed: 26059417
Cancer Res. 2008 Jul 15;68(14):5878-87
pubmed: 18632642
Asian Pac J Cancer Prev. 2014;15(2):577-83
pubmed: 24568460
Oncogene. 2013 Jan 17;32(3):277-85
pubmed: 22391564
J Cell Biol. 2012 Oct 29;199(3):407-12
pubmed: 23109665
Lab Anim Res. 2018 Dec;34(4):160-165
pubmed: 30671101
Histopathology. 2001 Oct;39(4):409-15
pubmed: 11683943
Cancer Sci. 2011 Jan;102(1):9-17
pubmed: 20735434
Adv Clin Exp Med. 2018 Jul;27(7):941-945
pubmed: 30019863
Cell Death Differ. 2012 Nov;19(11):1750-60
pubmed: 22555458
Sci Rep. 2017 Feb 01;7:41330
pubmed: 28145479
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Saudi Med J. 2019 Aug;40(8):766-773
pubmed: 31423512
J Cell Biochem. 2004 Oct 1;93(2):233-41
pubmed: 15368351
Neoplasia. 2013 Nov;15(11):1282-91
pubmed: 24339740
Cancer Res. 2007 Sep 15;67(18):8699-707
pubmed: 17875710
Br J Dermatol. 2017 Jul;177(1):168-178
pubmed: 27943259
Hum Cell. 2020 Apr;33(2):386-396
pubmed: 32065361
J Allergy Clin Immunol. 2018 Apr;141(4):1202-1207
pubmed: 29074454
Oncol Rep. 2013 Jun;29(6):2297-302
pubmed: 23589079
Neuro Oncol. 2017 Nov 6;19(suppl_5):v1-v88
pubmed: 29117289
Biochem Biophys Res Commun. 2009 Oct 16;388(2):400-5
pubmed: 19665999
J Ovarian Res. 2017 May 5;10(1):33
pubmed: 28476165
Cell Res. 2009 Apr;19(4):439-48
pubmed: 19238171
Exp Ther Med. 2019 Nov;18(5):3525-3533
pubmed: 31602229
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
pubmed: 16461460
Cell. 1997 Oct 17;91(2):231-41
pubmed: 9346240
J Surg Oncol. 2005 Jan 1;89(1):1-4
pubmed: 15611998
Cancer Invest. 2017 Oct 21;35(9):601-609
pubmed: 28990808
Ghana Med J. 2018 Sep;52(3):133-139
pubmed: 30602798
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W273-6
pubmed: 19406924
J Biol Chem. 2018 Jun 22;293(25):9570-9579
pubmed: 29695508
Leuk Lymphoma. 2007 Feb;48(2):410-2
pubmed: 17325905
J Clin Oncol. 2004 Dec 15;22(24):4958-65
pubmed: 15611510
Cancer. 2010 Dec 15;116(24):5637-49
pubmed: 20737563
Arch Dermatol Res. 2017 Mar;309(2):133-139
pubmed: 28013372
Oncotarget. 2017 Jul 11;8(28):46691-46703
pubmed: 28493839
Oncol Rep. 2015 Oct;34(4):2163-70
pubmed: 26239614
J Cell Mol Med. 2014 Oct;18(10):1913-26
pubmed: 25124875
N Engl J Med. 2005 Oct 27;353(17):1768-71
pubmed: 16251533
Exp Dermatol. 2013 Jun;22(6):426-8
pubmed: 23711067
Urol Oncol. 2007 Sep-Oct;25(5):387-92
pubmed: 17826655
Nucleic Acids Res. 2008 Jan;36(Database issue):D154-8
pubmed: 17991681
Cancer Res. 1986 Dec;46(12 Pt 1):6387-92
pubmed: 2946403
BMC Cancer. 2006 Jan 23;6:16
pubmed: 16430777
Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4349-54
pubmed: 11917134
Nucleic Acids Res. 2016 Jul 27;44(13):6019-35
pubmed: 27317695
Genetics. 1980 Oct;96(2):435-54
pubmed: 7262539
Biomaterials. 2011 Mar;32(7):1890-905
pubmed: 21167595
Cancer Lett. 2013 Jul 1;334(2):211-20
pubmed: 23073476
Sci Rep. 2020 Jul 21;10(1):12045
pubmed: 32694520
Mol Med Rep. 2017 Aug;16(2):1431-1438
pubmed: 28627687
Nat Commun. 2014 Dec 05;5:5671
pubmed: 25476932
Mod Pathol. 2017 Aug;30(8):1116-1125
pubmed: 28548126
Adv Drug Deliv Rev. 2014 Feb;66:74-89
pubmed: 24270010
Annu Rev Pathol. 2009;4:199-227
pubmed: 18817506
Asian J Androl. 2013 Nov;15(6):735-41
pubmed: 23974361
Mol Pharm. 2017 Sep 5;14(9):3121-3133
pubmed: 28719220
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W214-20
pubmed: 20576703
Cancer Treat Rev. 2014 Mar;40(2):276-84
pubmed: 24080154
World J Gastroenterol. 2019 Jul 28;25(28):3775-3786
pubmed: 31391772
PLoS One. 2014 Sep 03;9(9):e106343
pubmed: 25184537
Lipids Health Dis. 2006 Mar 03;5:4
pubmed: 16515689
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Biochim Biophys Acta Gen Subj. 2018 Apr;1862(4):1017-1030
pubmed: 29369785
Cancer Lett. 2017 Aug 28;402:1-8
pubmed: 28536008
Nat Rev Drug Discov. 2013 Nov;12(11):847-65
pubmed: 24172333
Nat Cell Biol. 2013 Oct;15(10):1153-63
pubmed: 23974039
J Clin Invest. 2014 Jul;124(7):3093-106
pubmed: 24911147
N Engl J Med. 1992 Dec 3;327(23):1649-62
pubmed: 1435901
J Investig Dermatol Symp Proc. 1996 Apr;1(2):188-94
pubmed: 9627715
Prostate. 2012 Feb 1;72(2):117-28
pubmed: 21538421
Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):662-670
pubmed: 29461593
Mol Cancer Res. 2013 Jul;11(7):759-67
pubmed: 23536707
J Cancer Res Clin Oncol. 2018 Dec;144(12):2419-2431
pubmed: 30244390
BMC Med Genomics. 2012 May 29;5:18
pubmed: 22643117
Cancer Res Treat. 2010 Sep;42(3):157-62
pubmed: 20948921
Pancreatology. 2020 Sep;20(6):1139-1148
pubmed: 32732173
J Cell Sci. 2010 Feb 15;123(Pt 4):606-18
pubmed: 20103531
Cancer Res. 2013 Sep 1;73(17):5402-15
pubmed: 23856247
EMBO J. 2002 Aug 1;21(15):4037-48
pubmed: 12145204
Signal Transduct Target Ther. 2016 Jan 28;1:15004
pubmed: 29263891
Biol Proced Online. 2018 Aug 8;20:16
pubmed: 30093840
Biochem Pharmacol. 2014 Feb 15;87(4):579-97
pubmed: 24370341
Am J Pathol. 2012 Dec;181(6):2188-201
pubmed: 23041061
Cancer Res. 2009 Mar 15;69(6):2287-95
pubmed: 19244118
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8933-8
pubmed: 12853564
J Cancer Sci Ther. 2015;7(11):336-346
pubmed: 26819679
Cell. 2007 Jun 29;129(7):1401-14
pubmed: 17604727
Cancer Cell. 2008 Mar;13(3):188-92
pubmed: 18328423
Breast Cancer Res. 2015 Feb 10;17:17
pubmed: 25849559
Front Biosci. 2006 May 01;11:1244-54
pubmed: 16368510
Curr Drug Targets. 2010 Sep;11(9):1059-73
pubmed: 20545613
Future Med Chem. 2014;6(17):1967-84
pubmed: 25495987
Oncol Lett. 2019 Jan;17(1):843-848
pubmed: 30655837
Stem Cells. 2018 Dec;36(12):1875-1889
pubmed: 30267595
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9
pubmed: 12434020
Theranostics. 2018 Jan 1;8(4):1106-1120
pubmed: 29464002
Virus Genes. 2011 Apr;42(2):157-61
pubmed: 21113793
J Neurosurg. 2016 Jan;124(1):122-8
pubmed: 26230475
Nucleic Acids Res. 2019 Sep 5;47(15):7753-7766
pubmed: 31340025
J Cell Sci. 2013 May 15;126(Pt 10):2256-66
pubmed: 23525011
Oncotarget. 2018 Jun 15;9(46):27920-27928
pubmed: 29963251
Carcinogenesis. 2006 Jan;27(1):1-22
pubmed: 16195239
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19300-5
pubmed: 19033458
RNA Biol. 2010 May-Jun;7(3):300-4
pubmed: 20436283
J Thorac Cardiovasc Surg. 2008 Feb;135(2):255-60; discussion 260
pubmed: 18242245
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
Avicenna J Med Biotechnol. 2010 Oct;2(4):161-79
pubmed: 23407304
Science. 2003 Mar 7;299(5612):1540
pubmed: 12624257
Adv Drug Deliv Rev. 2015 Jan;81:128-41
pubmed: 24859533
Nat Cell Biol. 2008 May;10(5):593-601
pubmed: 18376396
Asian Pac J Cancer Prev. 2014;15(9):4033-7
pubmed: 24935592
Cancer Res. 2009 Mar 15;69(6):2195-200
pubmed: 19276373
Cell Death Differ. 2010 Feb;17(2):229-35
pubmed: 19609273
Cancer Res. 2011 Nov 1;71(21):6590-600
pubmed: 21900402
Biomaterials. 2014 Aug;35(25):7077-87
pubmed: 24836307
Biochem Biophys Res Commun. 2013 Nov 8;441(1):139-43
pubmed: 24129185
PLoS One. 2012;7(7):e41462
pubmed: 22859986
Oncotarget. 2017 Apr 25;8(17):28042-28051
pubmed: 28427207
Nat Rev Clin Oncol. 2011 Nov 29;9(1):16-32
pubmed: 22124364
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15312-7
pubmed: 22949650
J Transl Med. 2011 Mar 22;9:30
pubmed: 21426561
Biochim Biophys Acta. 2002 Jun 21;1602(2):131-50
pubmed: 12020800
Oncotarget. 2017 May 9;8(19):30817-30829
pubmed: 28199217
Hepatology. 2009 May;49(5 Suppl):S72-84
pubmed: 19399801
Int J Mol Sci. 2013 Feb 08;14(2):3802-16
pubmed: 23396109
Br J Cancer. 2012 Jan 31;106(3):553-61
pubmed: 22223089
Lancet Oncol. 2014 Aug;15(9):e395-403
pubmed: 25079102
Biomed Rep. 2016 Oct;5(4):395-402
pubmed: 27699004
Mol Cell. 1998 Sep;2(3):305-16
pubmed: 9774969
Mod Pathol. 2012 Jan;25(1):86-99
pubmed: 21983934
Ont Health Technol Assess Ser. 2015 May 01;15(10):1-64
pubmed: 26366236
Oncotarget. 2016 Jul 5;7(27):42159-42171
pubmed: 27283988
Mol Med Rep. 2018 May;17(5):6253-6260
pubmed: 29488611
Lab Invest. 2012 Jul;92(7):1084-96
pubmed: 22525428
Oncogene. 2012 Apr 12;31(15):1869-83
pubmed: 21892204
Oncol Lett. 2016 Feb;11(2):1105-1109
pubmed: 26893700
Eur Rev Med Pharmacol Sci. 2016;20(1):92-100
pubmed: 26813458
PLoS One. 2012;7(10):e46990
pubmed: 23056551
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18144-9
pubmed: 24154725
Head Neck. 2013 May;35(5):720-8
pubmed: 22605671
PLoS One. 2012;7(4):e35158
pubmed: 22514717
Neurosurg Focus. 2015 Jan;38(1):E6
pubmed: 25552286
Oncol Rep. 2012 Apr;27(4):1200-6
pubmed: 22159356
J Cell Biol. 2001 Mar 19;152(6):1247-54
pubmed: 11257124
Nat Rev Cancer. 2001 Oct;1(1):34-45
pubmed: 11900250
Yi Chuan. 2009 Nov;31(11):1094-100
pubmed: 19933089
Cell Cycle. 2012 Feb 15;11(4):785-96
pubmed: 22374676
Prostate. 2012 Jun 15;72(9):991-7
pubmed: 22024950
Br J Dermatol. 2002 Jan;146(1):18-25
pubmed: 11841362
J Cancer. 2014 Sep 16;5(8):696-705
pubmed: 25258651
Cancer Res. 2011 Apr 1;71(7):2611-21
pubmed: 21330408
Lancet Oncol. 2004 Jun;5(6):372-80
pubmed: 15172358
Biochem Biophys Res Commun. 2007 Jun 22;358(1):12-7
pubmed: 17475218
Am J Transl Res. 2015 Oct 15;7(10):2053-9
pubmed: 26692949
Genome Biol. 2019 Jan 22;20(1):18
pubmed: 30670076
Elife. 2015 Aug 12;4:
pubmed: 26267216
Cancer Med. 2016 Aug;5(8):1917-46
pubmed: 27282910